Contact this trialFirst, we need to learn more about you.
Enzyme Replacement Therapy
PR001 for Parkinson's Disease
Recruiting1 awardPhase 1 & 2
Maitland, Florida
This trial is testing a new drug to treat Parkinson's disease in patients with a pathogenic GBA1 mutation. The study will last 5 years and will evaluate the safety, tolerability, immunogenicity, biomarkers, and clinical efficacy measures of the drug.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.